Global Animal Parasiticides Market 2017-2021

  • ID: 4143997
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Animal Medics
  • Bio-Vet
  • Dechra Pharmaceuticals
  • Huvepharma
  • Merck Animal Health
  • Norbrook
  • MORE
About Animal Parasiticides

Veterinary parasiticides or antiparasitics are products that kill parasites that infest livestock, pets, and other animals. The global animal parasiticides market is expected to grow at a moderate pace driven by the rise in demand for animal proteins and the increased focus on food safety. The increase in animal population will also help boost market growth. Bayer HealthCare, Elanco, Merial, Merck Animal Health, and Zoetis are the major vendors in the market. These vendors offer a wide portfolio of products in various segments such as animal diagnostics, animal vaccines, animal pharmaceuticals, and animal feed additives. These products are intended for use in companion animals and livestock. These products have active ingredients that kill or inhibit growth and a series of non-active ingredients such as stabilizers and solvents.

The analysts forecast the global animal parasiticides market to grow at a CAGR of 5.87% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global animal parasiticides market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Animal Parasiticides Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Bayer HealthCare
- Elanco
- Merck Animal Health
- Merial
- Zoetis

Other prominent vendors
- Animal Medics
- Biogénesis Bagó
- Bio-Vet
- Boehringer Ingelheim
- Ceva Santé Animale
- Dechra Pharmaceuticals
- ECO Animal Health
- Huvepharma
- Indian Immunologicals
- Lillidale Animal Health
- Mobedco-Vet (The Arab Pesticides & Veterinary Drugs)
- Neogen
- Norbrook
- Orion
- Phibro Animal Health
- Vétoquinol
- Virbac
- Vitafor

Market drivers
- Rise in incidences of zoonotic diseases.
- For a full, detailed list, view the full report

Market challenges
- Lengthy regulatory approval process.
- For a full, detailed list, view the full report

Market trends
- Vertical integration in livestock industry.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Animal Medics
  • Bio-Vet
  • Dechra Pharmaceuticals
  • Huvepharma
  • Merck Animal Health
  • Norbrook
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: Veterinary drug approval process
  • NADAs and supplements
  • ANADAs and supplements
  • CNADAs
PART 06: Market Landscape
  • Market overview
  • Five forces analysis
PART 07: Market segmentation by type of animals

PART 08: Market segmentation by product category
  • Ectoparasiticides
  • Endoparasiticides
  • Endectocides
PART 09: Geographical segmentation
  • Parasiticides market in Americas
  • Parasiticides market in EMEA
  • Parasiticides market in APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 12: Market trends
  • Vertical integration in livestock industry
  • Increase in R&D activities
  • Industry-academia collaborations
PART 13: Vendor Landscape
  • Competitive scenario
  • Other prominent vendors
PART 14: Key vendor analysis

PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Parameters for FDA approval
Exhibit 02: Overview of global animal parasiticides market
Exhibit 03: Factors influencing global animal parasiticides market 2016
Exhibit 04: Global animal parasiticides market snapshot: Developed and emerging markets 2016
Exhibit 05: Global animal parasiticides market 2017-2021($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global animal parasiticides market segments by type of animals
Exhibit 08: Global animal parasiticides market by product category 2016
Exhibit 09: Global ectoparasiticides market 2016-2021 ($ millions)
Exhibit 10: Global endoparasiticides market 2016-2021 ($ millions)
Exhibit 11: Global endectocides market 2016-2021 ($ millions)
Exhibit 12: Segmentation of global animal parasiticides market based on geography 2016 and 2021
Exhibit 13: Global animal parasiticides market revenue by geography 2016-2021 ($ millions)
Exhibit 14: Market scenario in Americas

Exhibit 15: Animal parasiticides market in Americas 2016-2021 ($ millions)
Exhibit 16: Market scenario in EMEA

Exhibit 17: Animal parasiticides market in EMEA ($ millions)
Exhibit 18: Market scenario in APAC
Exhibit 19: Animal Parasiticides market in APAC ($ millions)
Exhibit 20: Impact of drivers and challenges in global animal parasiticides market

Exhibit 21: Impact of drivers
Exhibit 22: Impact of challenges
Exhibit 23: Strategic success factors of companies in global animal parasiticides market
Exhibit 24: Bayer HealthCare: Key highlights
Exhibit 25: Bayer HealthCare: Strength assessment
Exhibit 26: Bayer HealthCare: Strategy assessment
Exhibit 27: Bayer HealthCare: Opportunity assessment
Exhibit 28: Elanco: Key highlights
Exhibit 29: Elanco: Strength assessment
Exhibit 30: Elanco: Strategy assessment
Exhibit 31: Elanco: Opportunity assessment
Exhibit 32: Merck Animal Health: Key highlights
Exhibit 33: Merck Animal Health: Strength assessment
Exhibit 34: Merck Animal Health: Strategy assessment
Exhibit 35: Merck Animal Health: Opportunity assessment
Exhibit 36: Merial: Key highlights
Exhibit 37: Merial: Strength assessment
Exhibit 38: Merial: Strategy assessment
Exhibit 39: Merial: Opportunity assessment
Exhibit 40: Zoetis: Key highlights
Exhibit 41: Zoetis: Strength assessment
Exhibit 42: Zoetis: Strategy assessment
Exhibit 43: Zoetis: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Animal Medics
  • Bio-Vet
  • Dechra Pharmaceuticals
  • Huvepharma
  • Merck Animal Health
  • Norbrook
  • MORE
New Report Released: – Global Animal Parasiticides Market 2017-2021

The author of the report recognizes the following companies as the key players in the global animal parasiticides market: Bayer HealthCare, Elanco, Merck Animal Health, Merial, and Zoetis.

Other Prominent Vendors in the market are: Animal Medics, Biogénesis Bagó, Bio-Vet, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Mobedco-Vet (The Arab Pesticides & Veterinary Drugs), Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac, and Vitafor.

Commenting on the report, an analyst from the research team said: “One trend in market is increase in R&D activities. Market leaders are increasing their investments in R&D for the development of new animal food and health products. Zoetis is focusing on R&D to broaden its product and vaccine ranges for other new species of animals worldwide. Its current R&D facilities are close to manufacturing sites to reduce transportation costs and increase production efficiency. The Iowa State University and Zoetis signed a collaborative agreement to develop a vaccine for the porcine epidemic diarrhea virus in the US. These R&D activities help in increasing the products and services in the market, thereby increasing the market size. For instance, Zoetis had about 180 product approvals in 2014, demonstrating a high level of R&D productivity in the market.”

According to the report, one driver in market is rise in incidences of zoonotic diseases. Zoonosis (zoonotic disease) is an infectious disease that is transmitted between species from animals to humans. Practices such as high stocking densities of animals in feedlots, long transportation times, and poor hygienic conditions at slaughterhouses increase the chances of acquiring zoonotic infections. The increasing consumption of animal meat has also increased the chances of exposure to food-borne pathogens, thereby increasing the risk of acquiring these diseases. The adoption of the intensive animal food farming has increased the risk of developing infectious diseases from organisms such as Campylobacter and Salmonella. The European Centre for Disease Prevention and Control and the European Food Safety Authority reported the compiled results for the occurrence of zoonoses and food-borne outbreaks in the European Union (EU).

Further, the report states that one challenge in market is generic erosion. The high availability of generic drugs in the animal market may hinder the growth prospective for animal parasiticides. Patent expiries of approved animal products adversely impact the market growth and result in the loss of an exclusive market, leading to rapidly declining sales. Usually, off patent drugs lose their market shares to lower-priced generic alternatives, thereby affecting the market size of the innovator drug. For instance, selamectin, the compound present in STRONGHOLD and REVOLUTION, the antiparasitic drugs from Zoetis for protection against fleas, ear mites, and heartworm disease in cats and dogs, is expired in January 2014. This initiated the generic introduction of similar drugs in the market, resulting in value erosion of the innovator drug. Additionally, FRONTLINE plus, the most preferred flea control product by Merial, lost its patent on one of the APIs in 2011, allowing multiple generics to enter into the market. Such generic availability of drugs result in volume growth for the market as they are reasonably cheaper than the branded products and hence, buyers can easily afford them. However, such instances are not good for the value growth of the market considering these generics are generally priced at 60%-70% discount of original branded drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Bayer HealthCare
  • Elanco
  • Merck Animal Health
  • Merial
  • Zoetis
  • Animal Medics
  • Biogénesis Bagó
  • Bio-Vet
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Dechra Pharmaceuticals
  • ECO Animal Health
  • Huvepharma
  • Indian Immunologicals
  • Lillidale Animal Health
  • Mobedco-Vet (The Arab Pesticides & Veterinary Drugs)
  • Neogen
  • Norbrook
  • Orion
  • Phibro Animal Health
  • Vétoquinol
  • Virbac
  • Vitafor
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll